To include your compound in the COVID-19 Resource Center, submit it here.
Immuno-oncology company TapImmune Inc. (NASDAQ:TPIV) named Peter Hoang president and CEO. He was SVP of business development and strategy at Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM).
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury